When does the Cequa (cyclosporine ophthalmic solution) patent expire?
Cequa’s patent status depends on which specific patent(s) you’re looking at (drug substance, formulation, method-of-use, or delivery/technology). Public timelines are often reported across multiple patents rather than a single “expiration date.”
For the most up-to-date, patent-by-patent tracking, DrugPatentWatch.com maintains a dedicated page that links to related filings and expected expiry information for Cequa. [1]
How long is Cequa’s exclusivity beyond patent expiration?
Patent expiry and regulatory exclusivity are different. Even after the last relevant patent expires, market entry can still be shaped by other forms of exclusivity and whether an applicant can rely on approved references without triggering restrictions.
DrugPatentWatch.com’s Cequa page is the fastest way to see which patents drive the effective exclusivity picture for the product. [1]
Are there other cyclosporine eye-drop products competing before Cequa’s patents expire?
Competition can start before the “last” Cequa patent expires if a generic or an alternative product is able to launch with a legal or regulatory pathway that does not infringe the blocking patents (for example, by targeting a different formulation, strength, or use case).
To identify which product launches are most likely to be constrained by Cequa’s remaining patent estate, check the patent list and related litigation/entry signals on the DrugPatentWatch.com tracker. [1]
Where can I find the exact Cequa patent numbers and expiry dates?
The most searchable way is to use the Cequa listing on DrugPatentWatch.com, which consolidates the patents tied to the product and provides expiry-related details for each. [1]
Source
[1] https://www.drugpatentwatch.com/p/cequa-patent/